Three Years Since Court Victory & Prescription Drug Copay Assistance Still Not Counting for Patients

At a time when the American people are focused on the affordability crisis and concerned about how much they pay for their prescription medications, the federal government can easily reduce their costs by complying with the court order and telling insurers they must count copay assistance towards patient cost-sharing. Instead, they are siding with the big insurers and drug middlemen, increasing their profits at the expense of patients who are struggling to afford their medications.
See the press release

HIV+Hep Praises DC, Massachusetts, and Delaware for Protecting PrEP Access

DC, Massachusetts, and Delaware have joined a growing number of states and jurisdictions acting to guarantee insurance coverage of highly effective HIV prevention medications known as PrEP without cost-sharing or prior authorization. These laws not only enshrine the coverage requirements into state law, but clarify that the full range of PrEP options, including newer long-acting injectables, must be covered.
See the press release

Mississippi Insurer Adds PrEP Coverage After Complaint, but Gaps Remain

We are pleased that Blue Cross Blue Shield of Mississippi has taken steps to comply with federal preventive coverage requirements by adding these two PrEP drugs. But by excluding other long-acting medications, which are recommended in national HIV treatment and prevention guidelines, Mississippians are still not able to access these highly effective drugs that improve patient adherence.
See the press release

House Republicans Propose $1 billion in Cuts to Domestic HIV Programs

We can’t imagine a country that is unable to conduct basic surveillance of a serious infectious disease, educate and test people, and link them to appropriate treatment or prevention, including PrEP. That is what would happen if the House Republican bill were to pass.
See the press release

CMS Fails to Exempt People Living with HIV from Medicaid Work Requirements

The law is very clear that people who have special medical needs, including those with a serious or complex medical condition, are statutorily exempt from the community engagement requirement. People living with HIV have a lifelong serious and complex medical condition and have special medical needs—they cannot stay healthy without continuous access to lifesaving HIV treatment. Any gap will put them at risk of serious health consequences.
See the press release

Who We Are

Monitors policies that impact the prevention and treatment of HIV, viral hepatitis, and other health conditions in the United States.

Communicates with members of the HIV, hepatitis, and other patient group communities on key policy issues that impact their access to healthcare.

Educates policymakers and members of the media about efforts to end both HIV and hepatitis in the United States and to improve access to quality and affordable healthcare for people with or at risk of serious or chronic health conditions.

Key Issues

Causes We Care About, and So Should You!

HIV

Promote necessary funding, programs, and policies to end the HIV epidemic in the United States

HEPATITIS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

HEALTHCARE ACCESS

Promote necessary funding, programs, and policies to end viral hepatitis in the United States

Learn More

Facebook posts by @HIV+Hep

HIV and Hepatitis Policy Institute

3 weeks ago

HIV and Hepatitis Policy Institute
On National PrEP Day, @HIVHep Urges Congress to Pass Comprehensive PrEP Program. With Record Number of Sponsors, Bill Creates National Grant Program to Increase Uptake, Provide for the Uninsured & Guarantee Insurance Coverage: bit.ly/4hUgXZO ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

HIV and Hepatitis Policy Institute

3 weeks ago

HIV and Hepatitis Policy Institute
The HIV and Hepatitis Policy Institute's Carl Schmid presented data on prior authorization & prescription drugs before the National Association of Insurance Commissioners. 31% of first fills of brand name #Rx’s were rejected due to utilization management in exchange plans: bit.ly/4hwYbIT ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Tweets by @HIV+Hep

Pin It on Pinterest